Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models

Title
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models
Authors
Keywords
Pancreatic ductal adenocarcinoma, Tumor antigen, Genetically engineered mouse model, Early diagnosis, Ezrin
Journal
Journal of Hematology & Oncology
Volume 6, Issue 1, Pages 67
Publisher
Springer Nature
Online
2013-09-06
DOI
10.1186/1756-8722-6-67

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now